Published in J Allergy Clin Immunol on December 01, 1999
Epithelial antimicrobial peptides in host defense against infection. Respir Res (2000) 2.40
Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe (2010) 2.39
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev (2002) 2.20
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 1.41
Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci (2001) 1.29
Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax (2002) 1.16
Cellular and molecular mechanisms in environmental and occupational inhalation toxicology. GMS Curr Top Otorhinolaryngol Head Neck Surg (2004) 1.16
Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med (2010) 1.10
Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol (2005) 1.08
Experimental selection for Drosophila survival in extremely high O2 environments. PLoS One (2010) 1.05
Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol (2005) 1.03
Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol (2011) 1.01
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Persistence of mucosal mast cells and eosinophils in Shigella-infected children. Infect Immun (2003) 0.92
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases. World J Gastroenterol (2005) 0.89
Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2. J Leukoc Biol (2008) 0.88
Antimicrobial peptides increase tolerance to oxidant stress in Drosophila melanogaster. J Biol Chem (2010) 0.86
Role of defensins in the pathogenesis of chronic lung allograft rejection. Hum Immunol (2013) 0.84
Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal (2012) 0.83
High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection. World J Gastroenterol (2005) 0.83
Diesel exhaust particles increase IL-1beta-induced human beta-defensin expression via NF-kappaB-mediated pathway in human lung epithelial cells. Part Fibre Toxicol (2006) 0.82
Nuclear localization of HBD-1 in human keratinocytes. J Burns Wounds (2007) 0.80
The chromosomal protein HMGN2 mediates the LPS-induced expression of β-defensins in mice. Inflammation (2012) 0.79
Regulation of surfactant protein and defensin mRNA expression in cultured ovine type II pneumocytes by all-trans retinoic acid and VEGF. Int J Exp Pathol (2006) 0.78
Dynamic changes in neutrophil defensins during endotoxemia. Infect Immun (2001) 0.76
Defensins: The Case for Their Use against Mycobacterial Infections. J Immunol Res (2016) 0.75
Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis. Front Chem (2017) 0.75
Airway Epithelial Cell Cilia and Obstructive Lung Disease. Cells (2016) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Complex chronic comorbidities of COPD. Eur Respir J (2008) 3.84
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001) 3.49
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol (1992) 2.73
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J (2004) 2.70
[Hyperventilation: not a cause of panic attacks]. Ned Tijdschr Geneeskd (1993) 2.64
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J (1996) 2.05
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax (2005) 1.99
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J (2004) 1.95
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Sputum induction. Eur Respir J Suppl (2002) 1.88
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer (2006) 1.61
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J (2007) 1.60
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.59
Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med (1999) 1.57
CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy (2014) 1.56
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol (2000) 1.54
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy (1999) 1.52
Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull Eur Physiopathol Respir (1984) 1.52
Murine models of asthma. Eur Respir J (2003) 1.49
Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J (1994) 1.49
[Asthma therapy in children and adults. Recommendations of the German Respiratory League of the German Society of Pneumology]. Med Klin (Munich) (1998) 1.47
Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med (2001) 1.46
Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study. Clin Exp Allergy (1992) 1.46
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J (2006) 1.45
Lung sounds during allergen-induced asthmatic responses in patients with asthma. Am J Respir Crit Care Med (1996) 1.42
Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy (2009) 1.42
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
[Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie (2006) 1.40
Occurrence of a late response to exercise in asthmatic children: multiple regression approach using time-matched baseline and histamine control days. Eur Respir J (1996) 1.40
Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis (1997) 1.39
[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39
Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol (1987) 1.38
Histamine hypersensitivity induced by passive sensitization of human bronchus: effect of serum IgE depletion. Clin Exp Allergy (1998) 1.38
Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J (1997) 1.36
Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol (1997) 1.34
Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol (1998) 1.31
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 1.31
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J (2007) 1.30
IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology (1987) 1.30
Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br J Pharmacol (1991) 1.26
Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Investig Med (2000) 1.26
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol (1995) 1.26
Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest (1998) 1.25
Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol (1997) 1.25
Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med (1999) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol (1998) 1.24
Safety of sputum induction. Eur Respir J Suppl (2002) 1.23
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax (1992) 1.23
Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis (1997) 1.21
Asthma control and differences in management practices across seven European countries. Respir Med (2002) 1.21
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax (1996) 1.21
Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax (1999) 1.20
Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol (1995) 1.20
Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma. Pulm Pharmacol Ther (2005) 1.19
Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med (1995) 1.17
Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol (2008) 1.17
Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol (1989) 1.17
Three phenotypes of adult-onset asthma. Allergy (2013) 1.15
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy (2009) 1.15
Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J Am Soc Nephrol (1996) 1.14
Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol (1997) 1.14
Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol (2001) 1.13
Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med (1998) 1.11
Predominance of left-sided deep vein thrombosis and body weight. J Thromb Haemost (2010) 1.10
Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl (2002) 1.10
Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax (1998) 1.09
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J (2005) 1.09
Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol (1994) 1.09
Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. Int J Clin Pract (2006) 1.09